thalidomide has been researched along with Angiolymphoid Hyperplasia with Eosinophilia in 3 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Angiolymphoid Hyperplasia with Eosinophilia: Solitary or multiple benign cutaneous nodules comprised of immature and mature vascular structures intermingled with endothelial cells and a varied infiltrate of eosinophils, histiocytes, lymphocytes, and mast cells.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Khurana, A | 1 |
| Savitha, B | 1 |
| Rongioletti, F | 1 |
| Cecchi, F | 1 |
| Pastorino, C | 1 |
| Scaparro, M | 1 |
| Kottler, D | 1 |
| Barète, S | 1 |
| Quéreux, G | 1 |
| Ingen-Housz-Oro, S | 1 |
| Fraitag, S | 1 |
| Ortonne, N | 1 |
| Deschamps, L | 1 |
| Rybojad, M | 1 |
| Flageul, B | 1 |
| Crickx, B | 1 |
| Janin, A | 1 |
| Bagot, M | 1 |
| Battistella, M | 1 |
3 other studies available for thalidomide and Angiolymphoid Hyperplasia with Eosinophilia
| Article | Year |
|---|---|
Refractory angiolymphoid hyperplasia with eosinophilia: Complete resolution with low dose thalidomide.
Topics: Angiolymphoid Hyperplasia with Eosinophilia; Head; Hemangioma; Humans; Rare Diseases; Thalidomide | 2022 |
Successful management of refractory angiolymphoid hyperplasia with eosinophilia with thalidomide.
Topics: Angiolymphoid Hyperplasia with Eosinophilia; Disease Management; Female; Humans; Immunosuppressive A | 2016 |
Retrospective Multicentric Study of 25 Kimura Disease Patients: Emphasis on Therapeutics and Shared Features with Cutaneous IgG4-Related Disease.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Angiolymphoid Hyperplasia with | 2015 |